曲妥珠单抗进展后治疗：心脏毒性风险真的不会增加吗？ - Suppr

Trastuzumab beyond progression: is the risk of cardiac toxicity really not increased?

Morabito Alessandro, Piccirillo Maria Carmela, De Maio Ermelinda, Di Maio Massimo, Perrone Francesco

J Clin Oncol. 2009 Sep 20;27(27):e123; author reply e124-5. doi: 10.1200/JCO.2009.23.9327. Epub 2009 Aug 17.

Abstract

摘要

J Clin Oncol. 2009 Sep 20;27(27):e123; author reply e124-5. doi: 10.1200/JCO.2009.23.9327. Epub 2009 Aug 17.

J Clin Oncol. 2007 Dec 1;25(34):5532-3; author reply 5533-4. doi: 10.1200/JCO.2007.14.0657.

Expert Rev Anticancer Ther. 2007 Dec;7(12):1763-71. doi: 10.1586/14737140.7.12.1763.

Cancer Treat Rev. 2009 Nov;35(7):633-8. doi: 10.1016/j.ctrv.2009.06.007. Epub 2009 Jul 28.

Clin J Oncol Nurs. 2010 Oct;14(5):630-40. doi: 10.1188/10.CJON.630-640.

J Br Menopause Soc. 2006 Dec;12(4):172-4. doi: 10.1258/136218006779160517.

J Clin Oncol. 2010 Jul 20;28(21):3407-10. doi: 10.1200/JCO.2009.26.0125. Epub 2010 Jun 7.

Cancer. 2002 Oct 1;95(7):1592-600. doi: 10.1002/cncr.10854.

J Clin Oncol. 2009 Dec 1;27(34):e239; author reply e240-1. doi: 10.1200/JCO.2009.24.6918. Epub 2009 Nov 2.

Bull Cancer. 2004 Nov;91 Suppl 3:166-73.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。